Tag: eye therapy
IDT Australia secures $3.2M manufacturing contract for investigational eye therapy
ASX-listed IDT Australia Limited has been awarded a five-year contract valued at $3.2 million for the manufacture of NPI-001 tablets, an investigational treatment for retinitis pigmentosa (RP), a degenerative eye disease that can lead to vision loss.
Featured Article
Future-ready manufacturing: How AI and cloud ERP are transforming supply chains
As manufacturers face growing supply chain disruption, rising costs and increasing operational complexity, artificial intelligence (AI), cloud ERP and connected digital systems are becoming essential tools for improving visibility, resilience and decision-making.
